Document Classification

Section Type: RESULTS

Text: In anterior MI group : (1) At 3rd, 6th month PIIINP and BNP serum levels were significantly lower in the spironolactone group compared with those in control group [PIIINP (260. 2 + / - 59. 9) vs (328. 0 + / - 70. 3) ng/L, P = 0. 001, (197. 1 + / - 46. 3) vs (266. 7 + / - 52. 4) ng/L, P < 0. 001], [BNP (347. 4 + / - 84. 0) vs (430. 1 + / - 62. 9) ng/L, P < 0. 001, (243. 7 + / - 79. 7) vs (334. 6 + / - 62. 8) ng/L, P < 0. 001] ; (2) There were smaller LVEDD and LVESD in spironolactone group compared with those in control group after 6 months intervention [(51. 0 + / - 5. 5) vs (55. 6 + / - 4. 5) mm, P = 0. 005, (35. 7 + / - 4. 6) vs (39. 1 + / - 5. 6) mm, P = 0. 046].